Shares of Alembic Pharmaceuticals soared nearly 5 percent on October 9 after the drugmaker's oncology formulation facility in Panelav, Gujarat cleared the US Food and Drug Administration's inspections without any observations.The USFDA had inspected the facility on October 7 and 8. Following the regulatory clearance of the unit, shares of Alembic Pharma opened on a positive note and extended gains...

Lupin's share price rose in the early trade on July 15 after the company received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located in Dabhasa, Gujarat.At 09:29 am, Lupin was quoting at Rs 1,813.75, up Rs 16.65, or 0.93 percent, on the BSE.The EIR was issued after the last inspection of the facility conducte...

The popular view for today is that the market will open a gap and stay there for the rest of the session. The rally will likely be fueled by foreign portfolio investors covering their short positions in index futures and retail investors loading up on stocks for fear of missing out. Domestic funds flush with money have anyway been buyers and if the market stays higher, foreign institutional invest...

JSW Cement plans to invest around Rs 3,000 crore to set up a greenfield, integrated manufacturing facility in the Nagaur district of Rajasthan, the JSW Group-owned company said on May 21.The investment would be funded through a combination of equity and long-term debt, the company said.Indian cement makers are bullish on the demand environment amid increased government spending on infrastructure, ...

Shares of Jubilant Pharmova touched a 52-week high of 699.15 in early trade on April 18 after the company's arm received a 'voluntary action indicated' (VAI) status from the US Food and Drug Administration (US FDA).At 9:21 am, Jubilant Pharmova was quoting Rs 682.00, up Rs 10.40, or 1.55 percent, on the BSE.Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Pharma Limited, announced th...